Predicta Med is a platform that enables early detection and intervention selection of autoimmune diseases. Its platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient's care. A process which typically takes more than four years and at least four different doctors can be shortened significantly using the platform.
Predicta Med’s deep learning engine aggregates EMR and claims data, and enriches and analyzes this data using state-of-the-art learning techniques. The platform discovers patients at risk of having an autoimmune disease and provides actionable insights to enable optimal intervention.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Predicta Med Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jun 24, 2024
www.calcalistech.com
"A CEO has to be a doctor, politician, parent, and economic advisor" | CTech
#Management Changes
Jul 11, 2023
www.cedars-sinai.org
Meet the New Health-Tech Companies Joining the Cedars-Sinai Accelerator
#Investment #Partners
Feb 13, 2023
www.finsmes.com
Predicta Med Raises Investment From CerraCap Ventures
#Investment
Jun 8, 2022
www.israel21c.org
New technology speeds up diagnosis of 7 autoimmune diseases